Nano Vaccine For Hepatitis B Shows Promise For Third World; Nanoemulsion Could Save More Lives By Removing Current Vaccines' Drawbacks, University of Michigan Study  
8/13/2008 9:00:59 AM

EurekAlert -- Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. The disease and its complications cause an estimated 1 million deaths globally each year.